Pulling SEC filings + quote and writing the call…

Alset Inc.
Next earnings ≈ Sep 28, 2026 · est. from filing cadence
Trades below book but the book is unknowable — material weakness, 262% dilution and a web of distressed cross-holdings make AEI uninvestable.
Price / market cap vs. equity $52.1M cap vs $121M equity · FY2025
On the surface Alset looks like a deep-value net-asset play: at $1.34 the $52.1M market cap sits at ~43% of the $121M stockholders' equity, liabilities are a trivial $6.92M (0.06x equity), and $25.2M of cash covers nearly half the cap. But the P/S of 11.7 is a red herring — this is a diversified holding company, not an operating business, so the entire thesis rests on whether that $137M asset base is real and monetizable. The MD&A shows it is mostly equity stakes in other beaten-down microcaps: a 43.6% interest in DSS (NYSE American), 45.8% in Value Exchange International (OTC Expert Market), 29.0% in Sharing Services Global (OTC: SHRG), plus a portfolio of trading securities flipped for short-term gains — all illiquid, hard-to-mark, and themselves distressed.
The governance overlay makes those marks untrustworthy. Management explicitly discloses an unremediated material weakness as of 12/31/2025: too few staff to segregate duties or 'timely evaluate the accuracy and completeness of our financial statement disclosures.' When the assets are illiquid cross-holdings and the controls that value them are broken, the discount to book is not a margin of safety — it's the market pricing in that the book may not be worth book. The structure (co-CEOs and co-CFOs, an 85.8%-owned Singapore-listed subsidiary, operations across eight countries) compounds the opacity.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $19.8M | $4.48M | $22.1M | $21.1M | $4.47M |
| Gross profit | $8.50M | $748K | $7.51M | $8.33M | $1.25M |
| Operating income | -$15.0M | -$7.09M | -$2.87M | -$4.12M | -$15.2M |
| Net income | -$119M | -$40.5M | -$58.9M | -$3.97M | -$47.4M |
| Diluted EPS | — | -$6.22 | -$6.52 | -$0.43 | -$2.22 |
| Net margin | -601.1% | -903.7% | -266.9% | -18.8% | -1060.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Entered a new material definitive agreement (Item 1.01)
Q1 2026 report; net losses persist across diversified holding segments
Entered one material agreement and terminated another (Items 1.01/1.02)
FY25 revenue -79% to $4.5M, net loss $47.4M, material weakness in controls
Signed another material definitive agreement (Item 1.01)
Entered a material definitive agreement (Item 1.01)
Disclosed shareholder voting results from annual meeting (Item 5.07)
Q3 2025 report; continued operating losses and weak real-estate revenue
Annual proxy: director elections and routine governance matters
Sources: SEC EDGAR (CIK 0001750106, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/4/2026, 3:29:12 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 0 sales
| 2026-06-08 | Chan Heng Fai Ambrose Chief Executive Officer | Buy | 250K @ $2.00 | $500K |
| 2026-03-30 | Chan Heng Fai Ambrose Chief Executive Officer | Sell | 100K @ $0.98 | $98.7K |
| 2025-09-12 | Chan Heng Fai Ambrose Chief Executive Officer | Sell | 500K @ $2.67 | $1.34M |
1195 tracked peers · median